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Abstract 
 
Interictal activity is a hallmark in epilepsy diagnostics and is linked to neuronal 
hypersynchrony. Little is known about perturbations in human epileptic neocortical 
microcircuits, and their role in generating pathological synchronies. To explore 
hyperexcitability of the human epileptic network, and its contribution to convulsive activity, 
we investigated an in vitro model of synchronous burst activity spontaneously occurring in 
postoperative tissue slices derived from patients with or without preoperative clinical and 
electrographic manifestations of epileptic activity. Human neocortical slices generated two 
types of synchronies. Interictal-like discharges (classified as epileptiform events) emerged 
only in epileptic samples, and were hypersynchronous bursts characterized by considerably 
elevated levels of excitation. Synchronous population activity was initiated both in epileptic 
and non-epileptic tissue, with a significantly lower degree of excitability and synchrony, and 
could not be linked to epilepsy. However, in pharmacoresistant epileptic tissue, higher 
percentage of slices exhibited population activity, with higher local field potential gradient 
amplitudes. More intracellularly recorded neurons received depolarizing synaptic potentials, 
discharging more reliably during the events. Light and electron microscopic examinations 
showed slightly lower neuron densities, and higher densities of excitatory synapses in the 
human epileptic neocortex. Our data suggest that human neocortical microcircuits retain their 
functionality and plasticity in vitro, and can generate two significantly different synchronies. 
We propose that population bursts might not be pathological events while interictal-like 
discharges may reflect the epileptogenicity of the human cortex. Our results show that 
hyperexcitability characterizes the human epileptic neocortical network, and that it is closely 
related to the emergence of synchronies.  
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Key points summary 
• Hyperexcitability and hypersynchrony of neuronal networks are thought to be linked 
to the generation of epileptic activity both in humans and animal models. 
• Here we show that human epileptic postoperative neocortical tissue is able to generate 
two different types of synchronies, in vitro. 
• Epileptiform bursts occurred only in slices derived from epileptic patients and were 
hypersynchronous events characterized by high levels of excitability.  
• Spontaneous population activity emerged both in epileptic and non-epileptic tissue, 
with a significantly lower degree of excitability and synchrony, and could not be 
linked to epilepsy. 
• These results help us better understand the role of excitatory and inhibitory neuronal 
circuits in the generation of population events, and to define the subtle border between 
physiological and pathological synchronies. 
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Abbreviations  
CSD: current source density 
EEG: electroencephalogram 
HFO: high frequency oscillation 
IID: interictal-like discharge 
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LFPg: local field potential gradient 
MUA: multiple unit activity 
SPA: spontaneous synchronous population activity 
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Introduction 
 
Epilepsies are characterized by the presence of interictal spikes detected on scalp 
electroencephalographic (EEG) recordings, which are considered to reflect hypersynchronous 
and wide spread activation of neuronal circuits. Interictal discharges in both human and 
experimental focal epilepsies were described as high amplitude, fast EEG spikes followed by 
a slow wave (de Curtis & Avanzini, 2001). In vivo human experiments showed that 
neocortical interictal spikes were either generated locally, or propagated from distant sites, 
both with an initial current sink and a considerable increase in cellular firing (Ulbert et al., 
2004a). 
Substantial effort has been made to reveal whether the resected human cortical tissue 
retains its ability to generate convulsive activity if maintained in vitro (for review see Avoli et 
al., 2005). Spontaneous synchronous discharges are known to be generated by slices prepared 
from the human epileptic neocortex (McCormick, 1989; Köhling et al., 1998; Gorji et al., 
2002; Roopun et al., 2010; Pallud et al., 2014) or the hippocampal formation (Cohen et al., 
2002; Wozny et al., 2005; Huberfeld et al., 2007; Wittner et al., 2009; Huberfeld et al., 2011) 
in a physiological perfusion solution. When filtered as the EEG (1-100 Hz), the waveform of 
in vitro events (Cohen et al., 2002) resembled in vivo interictal discharges (Ulbert et al., 
2004a; Fabó et al., 2008). Other similarities include the increase of cellular activity and fast 
oscillations seen in wide band (1-3000 Hz) filtering (Wittner et al., 2009; Simon et al., 2014). 
Intracellularly, synchronous population events were reflected as large, complex postsynaptic 
potentials with or without synchronous cell firing (Schwartzkroin & Knowles, 1984; 
McCormick, 1989; Wittner et al., 2009; Pallud et al., 2014), involving both excitatory and 
inhibitory signaling (Schwartzkroin & Haglund, 1986; Köhling et al., 1998; Cohen et al., 
2002). These postsynaptic potentials were found more frequently in neurons deriving from the 
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epileptogenic zone than in those from adjacent neocortical tissue (Schwartzkroin & Knowles, 
1984). Since synchronous bursts could not be detected in non-primate neocortical slices 
(Köhling et al., 1998), and healthy human control is lacking for ethical reasons, most groups 
believed that they might be epilepsy related phenomena (Cohen et al., 2002; Huberfeld et al., 
2007; Roopun et al., 2010; Huberfeld et al., 2011; Pallud et al., 2014). However, similar 
synchronous events were generated by healthy monkey hippocampal tissue, as detected in 
intracellular records (Schwartzkroin & Haglund, 1986), and could also be evoked in human 
non-epileptic neocortical tissue by activating single pyramidal cells (Molnár et al., 2008; 
Szegedi et al., 2016), suggesting that synchronous population activity is not necessarily 
related to epileptic processes. 
The impaired balance of excitation and inhibition is the most conventional theory 
underlying interictal spike generation. Most of our knowledge about the cellular and network 
basis of cortical hyperexcitability comes from animal models (for review see McCormick & 
Contreras, 2001). Human focal cortical epilepsy is extensively studied in the limbic structures, 
and a wide range of data is available concerning the cellular properties of neocortical neurons 
(for review see Avoli et al., 2005). Prolonged depolarizations, all-or-none and graded bursts 
could be evoked by electrical stimulation in a subset of human neocortical neurons located in 
the epileptogenic area verified either by electrocorticography (Prince & Wong, 1981; Avoli & 
Olivier, 1989), or by imaging techniques (Strowbridge et al., 1992; Williamson et al., 2003). 
Signs of network hyperexcitability were found in the 4-aminopyridine model of ictal activity 
generated by human slices from patients with focal cortical dysplasia (for review see Avoli et 
al., 2005). Anatomical findings also support the presence of excess excitation in the epileptic 
neocortex. Higher numbers of excitatory axon terminals and a loss of inhibitory synapses 
were found in the neocortex of patients with temporal lobe epilepsy (Marco & DeFelipe, 
1997), as well as perturbed densities of excitatory-inhibitory synapses in areas of focal 
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cortical dysplasia (Alonso-Nanclares et al., 2005). Although the cellular properties underlying 
hyperexcitability have been widely explored in the human neocortex, little is known about 
how an impaired balance of excitation and inhibition of the neuronal network contributes to 
epileptic hypersynchrony in humans. 
The question of control tissue is always problematic in case of human studies. 
Anatomical studies usually include human autopsy tissue as control (for example: Tóth et al., 
2010), while electrophysiological studies typically operate with healthy monkey 
(Schwartzkroin & Haglund, 1986) or rodent tissue (Köhling et al., 1998; Heinemann et al., 
2000), sometimes together with its corresponding epilepsy model (for example Lehmann et 
al., 2000). Furthermore, sclerotic hippocampus is usually compared to non-sclerotic 
hippocampus derived from epileptic patients (Isokawa & Fried, 1996; Kivi et al., 2000; 
Gabriel et al., 2004; Williamson et al., 2005), and epileptogenic neocortex surrounding 
epileptogenic lesions is compared to adjacent, non-affected areas (Strowbridge et al., 1992; 
Williamson et al., 2003; Alonso-Nanclares et al., 2005; Thom et al., 2005). The best control 
available for human epileptic neocortex, i.e. tissue from non-epileptic patients, has been 
investigated in only one intracellular study so far (Prince & Wong, 1981). 
In the present work, we used spontaneous population bursts emerging in human 
neocortical slices as a network model for synchrony to examine excitatory processes 
contributing to epileptic activity. We demonstrate that excess excitation is present at the 
network level in the human epileptic neocortex compared to tissue derived from tumour 
patients without any preoperative clinical or electrographic appearances of seizures. We show 
that human neocortical slices can generate two distinct types of synchronous activities. Based 
on their occurrence and network characteristics we conclude that synchronous population 
activity (SPA) does not seem to be related to epileptic processes, whereas interictal-like 
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discharges (IID) seem to be associated to epilepsy. The anatomical and physiological 
differences of neocortical networks between humans and animals are also discussed. 
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Materials and methods 
 
Patients 
All patients gave written consent, and our protocol was approved by the Hungarian 
Ministry of Health. The study was approved by the Regional and Institutional Committee of 
Science and Research Ethics of Scientific Council of Health (ETT TUKEB 20680-
4/2012/EKU) and performed in accordance with the Declaration of Helsinki.  
 
Epileptic patients 
Epileptic tissue samples were obtained from 49 patients (Table 1). We obtained 
epileptic neocortical tissue from frontal (n=15 patients), temporal (n=25 patients), parietal 
(n=5 patients) and occipital (n=4 patients) lobes. Most of the patients (n=26) suffered from 
focal cortical epilepsy for 19.6±14.6 years on average. The scalp EEG showed the presence of 
interictal spikes in all these patients. The remaining 23 patients had brain tumours, and had 
recurrent epileptic seizures (n=12 patients) for 6.0±6.0 years on average, or had only one 
seizure (or status epilepticus) within 10±22 months prior their surgery (n=11 patients) and 
were therefore considered to be epileptic. Seventeen patients suffering from epilepsy+tumour 
had tumours of glial origin. Three of these 17 patients were operated for their glial tumour 
earlier, and now underwent their second operation to resect necrotic brain tissue caused by 
radiotherapy. Four patients had carcinoma metastasis. Two patients had other types of tumour 
(see Table 1). Thirteen epileptic patients were diagnosed with cortical dysgenesis, they were 
epileptic for 20.2±12.7 years on average. Focal cortical dysplasia was found in nine patients, 
two of them also suffered from hippocampal sclerosis. Four patients showed signs of other 
cortical dysgenesis. Hippocampal sclerosis was detected in 8 patients, who were epileptic for 
25.8±16.7 years on average. The remaining five patients had cavernoma (n=4) or viral 
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encephalitis (n=1), and were classified as “other”. The duration of epilepsy of these five 
patients was 8.0±10.3 years. Epileptic patients: 24 females, 25 males, age range: 18-72 years, 
mean±st.dev.: 40.1±16.1 years. 
 
Non-epileptic patients 
Thirty-three patients diagnosed with brain tumour but without epilepsy were included 
in this study (Table 1). These patients – as it is stated in their anamnesis – did not survive 
clinical manifestation of epileptic seizure before the date of their brain surgery. Preoperative 
clinical EEG recordings confirmed in eight of these patients that no electrographic signs of 
epileptic activity were present on their scalp EEG. We obtained non-epileptic neocortical 
specimens from frontal (n=10 patients), temporal (n=11 patients), parietal (n=7 patients) and 
occipital (n=5 patients) lobes. Fourteen patients were diagnosed with tumours of glial origin: 
glioblastoma (n=12) or anaplastic astrocytoma (n=2). Fourteen patients had carcinoma 
metastasis. The remaining five patients were operated for other reasons (for details see Table 
1). The distance of the obtained neocortical tissue from the tumour has been provided by the 
neurosurgeon, based on magnetic resonance (MR) images, intraoperative pictures and 
occasionally defined by navigational system. Non-epileptic patients: 18 females, 15 males, 
age range: 31-82 years, mean±st.dev.: 61.7±11.7 years. 
 
Tissue preparation 
Tissue was transported from the operating room to the laboratory (located in the same 
building) in a cold, oxygenated solution containing (in mM) 248 D-sucrose, 26 NaHCO3, 1 
KCl, 1 CaCl2, 10 MgCl2, 10 D-glucose and 1 phenol red, equilibrated with 5% CO2 in 95% 
O2. Neocortical slices of 500 µm thickness were cut with a vibratome. They were transferred 
and maintained at 35–37°C in an interface chamber perfused with a standard solution 
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containing (in mM) 124 NaCl, 26 NaHCO3, 3.5 KCl, 1 MgCl2, 1 CaCl2, and 10 D-glucose, 
equilibrated with 5% CO2 in 95% O2. 
 
Recordings 
Intracellular recordings were made with microelectrodes that contained 2M KAc with 
a resistance of 50–100 MΩ. The data were obtained within 10–20 min of penetration. Signals 
were amplified with a BA-1S amplifier (NPI Electronic GmbH, Tamm, Germany) operated in 
current-clamp mode. In acceptable records, the membrane potential was more negative than -
50 mV, input resistance was higher than 20 MΩ, and action potentials were overshooting. 
The extracellular local field potential gradient (LFPg) was recorded with a laminar 
multiple channel (24 channels, distance between contacts: 150 µm) microelectrode (Ulbert et 
al., 2001; Ulbert et al., 2004a; Ulbert et al., 2004b; Fabó et al., 2008; Wittner et al., 2009), 
using a custom made 48-channel voltage gradient amplifier of pass-band 0.01 Hz to 10 kHz. 
Signals were digitized with a 32 channel, 16-bit resolution analog-to-digital converter 
(National Instruments, Austin TX, USA) at 20 kHz sampling rate, recorded with a home 
written routine in LabView7 (National Instruments, Austin TX, USA). The linear 24 channel 
microelectrode was placed perpendicular to the pial surface, and slices were mapped from one 
end to the other at every 300-400 µm. 
 
Drugs 
 A type γ-aminobutyric acid (GABAA) receptor mediated signaling was suppressed by 
bicuculline methiodide (10 µM). AMPA (α-amino-3-hydroxyl-5-methyl-4-isoxazole-
propionate) and KA (kainate) type glutamate receptors were blocked using 2,3-dihydroxy-6-
nitro-7-sulfamoyl-benzo(f)quinoxaline (5 µM, NBQX) and NMDA (N-methyl-D-aspartate) 
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type receptors were blocked with DL-2-amino-5-phosphonovaleric acid (50 µM, DL-APV). 
Drugs were obtained from Tocris Bioscience (Izinta Kft., Hungary). 
 
Data analysis 
Data were analyzed with the Neuroscan Edit4.5 program (Compumedics Neuroscan, 
Charlotte, NC, USA), and home written routines for Matlab (The MathWorks, Natick, MA, 
USA). Current source density (CSD), an estimate of population trans-membrane currents, and 
multiple unit activity (MUA) were calculated from the LFPg using standard techniques 
(Ulbert et al., 2001; Ulbert et al., 2004b; Wittner et al., 2009). Baseline correction (-150 to -
50 ms) was applied to averaged LFPg, CSD and MUA. In the color maps, CSD sinks are 
presented in red, sources in blue. Warm colors (red) depict MUA-increases and cold colors 
(blue) depict MUA decreases compared to baseline. 
Synchronous activity (SPA and IID) detection was performed on LFPg records after a 
double Hamming window spatial smoothing and a band-pass filtering between 3 and 30 Hz 
(zero phase shift, 12 dB/octave). The peak of the LFPg transient was detected with a routine 
in Matlab, and was considered as time zero for further event triggered averaging. Events 
larger than 3x standard deviation were detected and included in the analyses. The location of 
SPAs/IIDs was determined in each case. The 24-channel microelectrode covered all layers of 
the neocortex in almost all cases. Usually channels 1-8 were in the supragranular, channels 9-
13 in the granular and channels 14-23 were in the infragranular layers. Channel positions were 
determined according to the thickness of the neocortex of the given patient, and corrected if 
necessary. Waveform analysis was performed on averaged synchronous activities with a 
home written C++ routine. 
Ripple and fast ripple components of SPAs and IIDs were determined with the aid of 
routines written in Matlab, as follows. Original 20 kHz sampling rate records were down 
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sampled to 2000 Hz. Wavelet analysis was applied on epochs containing 4096 sampling 
points (from -1000 ms to 1047 ms) with the LFPg peak of the SPA/IID at time zero (detected 
as above). Time-frequency analysis was performed between 0 and 800 Hz on the electrode 
channels where SPA was present, and baseline corrected to -300 to -100 ms. We 
systematically saw a peak around 200 Hz, and therefore we modified the conventional limit of 
200 Hz for ripple frequency (Bragin et al., 1999) to 250 Hz. For each channel, the maximal 
power change (relative to the baseline) was determined within the range of 130 to 250 Hz 
(ripple frequency) and 300 to 800 Hz (fast ripple frequency) at time zero (i.e. at the time point 
of the LFPg peak of the SPAs/IIDs). The frequencies where the power showed the maximum 
were also determined. Both the ripple and fast ripple power and frequencies were averaged 
across channels, to receive one ripple and one fast ripple power and frequency parameter for 
each recording. This last step was needed for the comparison of recordings with population 
activities spreading to different numbers of channels. 
 
Anatomy 
Intracellularly recorded cells were labelled, processed and reconstructed in three 
dimensions as described earlier (Wittner et al., 2009). 
Immunohistochemical procedures were used to verify the laminar structure and the 
possible tumour infiltration or signs of dysgenesis in the neocortex of 28 epileptic and 13 
tumour patients. Either tissue blocks or neocortical slices following electrophysiological 
recording were fixed and processed as described earlier (Wittner et al., 2009). Neuronal cell 
bodies were stained with NeuN antibody (1:2000, EMD Millipore, Billerica, MA, USA, 
RRID:AB_2298772), astroglial cells were stained with glial fibrillary acidic protein antibody 
(1:2000, EMD Millipore, Billerica, MA, USA, RRID:AB_94844), and perisomatic inhibitory 
cells were marked with parvalbumin antibody (1:7000, Swant, Bellinzona, Switzerland, 
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RRID:AB_10000343). All antibodies were mouse monoclonal antibodies. Their specificity 
was tested by the manufacturer. Visualization of immunopositive elements was performed as 
described earlier (Wittner et al., 2009). 
The total cell density and the synaptic connectivity were examined in regions which 
generated SPA and in neighboring regions that did not show SPA. The following criteria were 
taken into consideration when choosing the samples for quantitative analysis: the site that 
generated SPA and the site that did not generate SPA should be part of the same slice. The 
NeuN- or the PV-stained sections chosen for cell counting should contain the whole length of 
the slice, and the whole width of the cortex, including all layers. Two slices were chosen both 
from tumour (patients T17 and T23) and epileptic (patients E13 and E16) subjects for NeuN+ 
neuron counting. Four slices from three epileptic patients (E12, E13 and E15), and three slices 
from three non-epileptic patients (T17, T20 and T23) for counting PV+ cell bodies. Two 
regions were marked including all layers: one where SPA was detected and another where 
recordings did not show SPA. The areas of all neocortical layers were measured, and NeuN- 
or PV-positive somata were counted in both regions with the aid of the NeuroLucida system 
(MicroBrightField Inc. Williston, VT, USA), at a magnification of 40x.  
After light microscopic examination, areas of interest were re-embedded and sectioned 
for electron microscopy. Ultrathin serial sections were collected on Formvar-coated single 
slot grids, stained with lead citrate, and examined with a Hitachi 7100 electron microscope. 
Electron microscopic analysis was made only on specimens with high quality ultrastructural 
preservation. For the analysis of synaptic connectivity three slices from epileptic (E12, E13, 
E15) and three from non-epileptic (T17, T20, T23) patients were selected. SPA occurred in 
the supragranular layers in all selected slices. Two blocks were re-embedded from the 
supragranular layers (upper layer III) of each slice, one from the spot where SPA was 
recorded and the other from an area where SPA was not generated. Photos were 
 15 
 
systematically taken at 20 000x magnification, from one side to the other side of the block 
without overlapping areas, to avoid multiple sampling of the same synapse. The number of 
the examined spots varied between 22 and 39 among the samples, with an area of 30.57 µm2 
per spot. Neuronal and glial somata were excluded from the examined area, so, all values are 
given relative to the neuropil. The values of the examined area from each block varied 
between 2200 and 3400 µm2. The number of asymmetrical (presumably excitatory) and 
symmetrical (presumably inhibitory) synapses were determined per 100 µm2 in each region. 
 
Statistical analysis 
Our data sets were not following Gaussian distributions, therefore non-parametric tests 
were used. The Mann-Whitney U test was used when two groups; Kruskal-Wallis ANOVA 
was used when more than two groups were compared. In case of the latter, differences 
between groups were determined via post-hoc tests provided by Matlab. In case of multiple 
testing, p-values were corrected using the Bonferroni-Holm method.  
For testing the effect of DL-APV we used the paired Wilcoxon signed rank test. 
For contingency tables the Fisher exact test or Chi square test were used, if the 
expected values were low or high, respectively. 
P-values below 0.05 were considered to be statistically significant. 
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Results 
 
Occurrence of synchronous population activity 
Synchronous population activity (SPA) was spontaneously generated in a standard 
bathing solution in slices from both epileptic (n=133/287 slices, 46.3% in n=43/49 patients) 
and non-epileptic patients (n=60/194 slices, 30.9% in n=24/33 patients, significantly different, 
p<0.05, Fig. 1, for patient data see Methods and Table 1). In several cases (n=9 activities, 
3.1%, in n=7/287 slices, in n=5/49 epileptic patients), considerably larger and more complex 
bursts also emerged in the neocortex derived only from epileptic patients (Fig. 1G). They 
resembled epileptiform population bursts induced by 4-amino-pyridine (Avoli et al., 1994), 
and were therefore named interictal-like discharges (IID, see Fig. 1), and analysed separately. 
When separating IIDs from SPAs we considered every examined network features of the 
synchronous activities: layer of emergence, recurrence frequency, local field potential 
gradient (LFPg), current source density (CSD) and multiple unit activity (MUA) amplitude 
(see later in details). LFPg and CSD amplitude are related to each other, since CSD is the first 
derivative of LFPg signal (see Methods). LFPg gives the difference in local field potential 
between two neighbouring electrode contacts, and might be misrepresentative in case of 
synchronies spreading to higher numbers of contacts. In contrast, CSD amplitude gives an 
estimate of transmembrane current amplitude, independent from the spatial dimensions of the 
synchrony. Moreover, MUA amplitude can be misleading if a large amplitude single unit with 
related firing to the synchrony is visible on the trace. All these technical considerations were 
taken into account when establishing our categories. Although each property showed slightly 
overlapping values, combining all parameters gave a clear distinction between SPAs and IIDs. 
We combined CSD and MUA, to be able to visualise the examined features in a three-
dimensional plot (Fig. 1J). 
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SPA occurrence was similar in slices derived from different lobes (Table 2, p>0.1 and 
p>0.8 in epileptic and tumour tissue, respectively), but was significantly higher in tissue 
resected from patients with epilepsy than in slices derived from non-epileptic patients 
(p<0.01). SPA was generated at a significantly lower rate in slices from epileptic patients with 
tumour (n=23, 36.4±29.0%, mean±standard deviation) than from epileptic patients with 
dysgenesis (n=13), hippocampal sclerosis (n=8), or other associated symptoms (n=5, varying 
from 50.3±34.0% to 58.3±28.6%, p<0.05, Table 3). The specimens obtained from patients 
with dysgenesis were classified as affected (n=46 slices from seven patients) or non-affected 
(n=26 slices from five patients) by the dysgenesis, based on our subsequent anatomical 
analysis. We found similar values of SPA emergence in the dysgenetic (n=26/46 slices, 
56.5%) and in the non-dysgenetic (n=14/26 slices, 53.9%) neocortex (Chi-Square Test; 
p>0.8). 
SPA generation was variable in patients with brain tumour, relative to their type of 
tumour (Table 3). The SPA occurrence rate in all tumour patients with or without preoperative 
epileptic seizures was 32.4±27.4%. Higher, although not significant (p>0.1) ratios were found 
in the cases with glial tumour (38.7±28.6%, n=31 patients), and other associated symptoms 
(35.0±29.0%, n=7 patients), than in brains with carcinoma metastasis (20.6±21.3%, n=12 
patients). We verified how the distance of the specimen from the tumour affected SPA 
generation in our samples. In the cases where the resected neocortical tissue was close (<30 
mm) to the tumour, 25.0±22.8% of the slices generated SPA (in n=23 patients, for 
determination of the distance between the tumour and the resected neocortical tissue see 
Methods). When the examined tissue was at higher distances from the tumour (>30 mm, but 
in most cases >50 mm), SPA emerged in higher percentages of the slices (36.1±27.9%, in 
n=31 patients), although the difference was not statistically significant (p>0.1).  
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Next, we wished to examine whether the different stages of epilepsy affect the ability 
of the neocortex to generate SPAs. Therefore, we grouped our patients (Table 1) as follows: 
A) patients with pharmacoresistant epilepsy; B) patients with focal or grand mal seizures who 
are seizure free with medication (treatable epilepsy); C) patients with one grand mal seizure 
or with occasional (provoked) seizures, and with no need for medication (these patients were 
operated for their tumour); D) patients without preoperative seizures (no epilepsy). SPA 
occurrence was the highest in the group with pharmacoresistant epilepsy (group A, n=33 
patients): 57.0±28.0%; it was lower in the group with treatable epilepsy (group B, n=11 
patients): 32.3±13.9%. We found the lowest ratios in the group with no need for medication 
(group C, n=5 patients): 11.7±16.2%, and in the group without epilepsy (group D, n=33 
patients): 29.1±26.4%. SPA occurrence was related to the stage of epilepsy, i.e. the ratio of 
slices generating SPA in group A was significantly higher than in group D (p<0.001) or in 
group C (p<0.01). 
Our above analyses show that both the presence of tumour and the stage of the 
patient’s epilepsy influence the generation of synchronies. In this study, we wished to identify 
epilepsy related phenomena, which are not affected by tumour formation or by differences in 
the stages of epilepsy. Thus, for the analysis of network and cellular properties of the 
synchronies, we made three groups as follows. 1) Patients with pharmacoresistant epilepsy 
and without tumour (will be referred as “epileptic”). Note that this category largely overlaps 
with group A, but excludes patients with tumour and pharmacoresistant epilepsy. 2) Tumour 
patients without epilepsy (will be referred as “tumour”), this category includes patients falling 
into group D. 3) The remaining patients suffering from both epilepsy and tumour were pooled 
into the heterogeneous “epileptic+tumour” group (see Table 1). We analyzed data deriving 
from these groups separately, and made comparisons only between “epileptic” and “tumour” 
patients to draw conclusions about changes related to epilepsy. 
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Characteristics of SPAs and IIDs 
Several types of SPAs were separated by their location and extension within the 
neocortex (Fig. 2A, Table 4). SPA occurred most frequently in the supragranular layers: 
69.9% in epileptic, 65.2% in epileptic+tumour and 67.3% in tumour tissue (Fig. 2B, see also 
(Köhling et al., 1998). Less often SPA could be detected in the granular and infragranular 
layers, and in a few cases SPA invaded the entire width of the neocortex. Interictal-like 
discharges (IID) emerged mainly in the deeper layers of the neocortex: granular (n=1) or in 
the granular+infragranular (n=5) and infragranular (n=2) layers (Fig. 2A, B, Table 4) in slices 
from epileptic patients, and in the supragranular+granular layers (n=1) in one slice from a 
patient having epilepsy+tumour. 
As in a previous study (Köhling et al., 1998), we observed multiple independent SPAs 
in the same slice. We differentiated between simultaneous multiple SPAs (Fig. 2B) or 
simultaneous SPA+IID (n=2 cases, Fig. 1G) at one recording site, and multiple spots of SPAs 
(Fig. 2C). The ratio of slices exhibiting multiple SPAs was somewhat higher in epileptic 
(33.3%) and epileptic+tumour (32.7%) than in tumour patients (25.0%, Table 4).  
Next, the network characteristics of SPAs and IIDs emerging in the human neocortex 
were analyzed (Fig. 1I, Table 5). We compared SPAs emerged in epileptic slices to SPAs 
generated in tumour slices, as well as to IIDs detected in epileptic tissue. The recurrence 
frequency of SPAs was 1.20±0.71 Hz in epileptic (n=46 SPAs) and 1.18±0.63 Hz in tumour 
(n=48 SPAs) tissue, respectively, while that of IIDs was significantly lower (0.10±0.13 Hz, 
n=8 IIDs, p<0.0001). The largest amplitude on the local field potential gradient (LFPg) was 
significantly higher for IIDs (74.70±21.99 µV) than for SPAs (23.22±17.23 µV, p<0.0001) in 
the neocortex of epileptic patients, and it was significantly lower for SPAs in tumour patients 
(18.40±10.48 µV, p<0.01, Table 5), than for SPAs in epileptic patients. Multiple unit activity 
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(MUA), as an estimate of cellular firing, did not differ during SPAs in epileptic and tumour 
tissue (1.49±1.46 vs. 1.29±1.17 µV, respectively), but was significantly higher during IIDs 
(6.46±4.57 µV, p<0.01, Fig. 1H-I). Similar to a previous study (Köhling et al., 1999), we 
found that the current source density (CSD) associated with the SPAs was very variable. 
However, in most of the cases a source-sink-source pattern was detected in the layer where 
the SPA occurred (Fig. 1B, D, F). The CSD pattern was usually more complex, comprising 
several peaks, and significantly higher in amplitude during IIDs (Fig. 1H, p<0.0001). 
A relationship between the recurrence frequency and the field potential amplitude has 
been previously observed in case of population events in vitro (Papatheodoropoulos & 
Kostopoulos, 2002; Hofer et al., 2015), i.e. as the frequency of events increases as a 
consequence of higher levels of [K+]o, the field potential amplitude decreases. On the other 
hand, this relationship could not be demonstrated in case of population bursts without 
changing the composition of the physiological bath solution (Hájos et al., 2013). To verify 
this possible correlation during human neocortical synchronies, we plotted the average LFPg 
amplitude of SPAs/IIDs against the mean recurrence frequency or the mean inter event 
interval. We could not find a considerable correlation between LFPg amplitude and frequency 
(R2=0.0042 for SPA and R2=0.006 for IIDs), or inter event interval (R2=0.0011 for SPAs and 
R2=0.0957 for IIDs). However, when plotting MUA amplitude against LFPg amplitude, we 
found a weak correlation for SPAs (R2=0.3679), indicating that larger LFPg (reflecting 
synaptic input, (Gulyás et al., 2010) is linked to larger MUA (reflecting output). No 
correlation could be demonstrated in case of IIDs (R2=0.0135). We also examined the 
relationship between the LFPg amplitude of every SPA/IID event and the length of its 
preceding inter event interval within each recording. In the majority of the cases (n=65/102) 
no significant correlation was demonstrated. In about third of the cases (n=30/102) a 
significant positive correlation was shown (with very weak to moderate Spearman correlation 
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coefficients), but we also found negative correlations (n=7/102, with very weak to weak 
Spearman correlation coefficients). None of the IID activities were significant, possibly due to 
the low IID event numbers. Altogether, correlations could be either positive or negative in 
both epileptic and tumour tissue, but only positive correlations showed moderate strength 
(data not shown). 
High frequency oscillations (HFOs) were examined in the range of ripples (130-250 
Hz) and fast ripples (300-800 Hz) during SPAs in slices derived from both epileptic (n=37 
slices from 12 patients) and tumour patients (n=33 slices from 9 patients, Fig. 3, Table 6), as 
well as during IIDs in 8 recordings from epileptic patients without tumour. Simultaneous 
multiple SPA was present in 8/37 and 11/33 recordings, therefore 46 and 48 SPAs were 
examined in epileptic and tumour tissue, respectively. HFOs (mainly at ripple frequency) 
associated to SPAs were detected slightly (but not significantly) more frequently in slices 
from epileptic than from tumour patients (Table 6). Ripple frequency was significantly lower 
during SPAs in epileptic than in tumour tissue (p<0.01). Fast ripple frequency was similar in 
epileptic and tumour tissue, and showed slightly lower values during IIDs. Ripple and fast 
ripple powers during SPAs did not differ in epileptic vs. tumour tissue, but were significantly 
higher during IIDs (p<0.001 for both ripple and fast ripple powers, Table 6, Fig. 3). 
 
Role of glutamate and GABA receptors in the generation of SPAs 
To reveal the role of glutamate and GABA signaling in the generation of SPAs, we 
applied the AMPA/kainate glutamate receptor agonist NBQX (5 µM), or the GABAA receptor 
agonist bicuculline (10 µM) on human neocortical slices. As described previously (Köhling et 
al., 1998), SPAs were reversibly suppressed by blocking either AMPA/kainate receptors (n=4 
and n=5 SPAs in slices from 3 tumour and 4 epileptic patients, respectively, Fig. 2E) or 
GABAA receptors (n=8 and n=9 SPAs in slices from 6 tumour and 8 epileptic patients, 
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respectively). The role of NMDA receptors was investigated with the application of its 
antagonist DL-APV (50 µM), which significantly reduced the recurrence frequency of SPAs 
(n=4 from 3 tumour patients, n=5 from 4 epileptic patients) to 80.16 [58.63 - 99.17] % 
(p<0.05), and diminished the LFPg and MUA amplitudes to 90.68 [81.81 - 105.05] and 86.78 
[69.53 - 110.81] %, respectively (both 0.05<p<0.1, Fig. 2E). 
 
Intracellular correlates of SPAs 
Putative pyramidal cells were intracellularly recorded in neocortical slices from 
epileptic (n=17) and from tumour (n=16) patients (Fig. 4, Table 7), simultaneously with the 
extracellular linear recordings.  
Subsequent anatomical studies in case of nine cells (six from epileptic and three from 
tumour tissue; see Table 7) confirmed that intracellularly recorded neurons were indeed 
pyramidal cells. All intracellularly filled cells showed the characteristics of pyramidal cells: a 
triangular cell body, a long and thick apical dendrite and numerous thin basal dendrites, 
covered by mainly thin and mushroom spines. Four well filled cells (one from tumour tissue, 
three from epileptic tissue, one located in layer II, three in layer V) were reconstructed in 
three dimensions (Fig. 4G, H), and had an average total dendritic tree length of 34.04±9.28 
mm. We should note that the real dendritic length of our human neocortical pyramidal cells 
was even higher, since the apical dendrite of three cells was truncated because of the slice 
preparation procedure. 
Both the resting membrane potential and the ratio of spontaneously firing/silent cells 
at resting membrane potential were similar in epileptic and tumour tissue (Table 7; Mann-
Whitney U Test; p=0.69 and Fisher’s exact test; p=0.31, respectively). 
As in previous studies (Köhling et al., 1998; Roopun et al., 2010; Pallud et al., 2014), 
different types of cellular behaviors were detected during SPA (Fig. 4A-E). Cells in the 
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epileptic slice preparations showed either depolarizing (n=11/12 cells, 91.7%) or 
hyperpolarizing (n=1/12 cells, 8.3%) responses to SPA. At resting potential, seven 
depolarizing cells (58.3% of responding cells) also fired during SPA, at 43.5 [29.8-86.7] % of 
the events (median [±95% confidence interval]; Fig. 4F). 
In the tumour tissue, we found neurons showing depolarizing (n=6/13 cells, 46.2%, 
significantly different from epileptic samples, p<0.05), hyperpolarizing (n=4/13 cells, 30.7%) 
or biphasic responses (n=3/13 cells, 23.1%), which consisted of a hyperpolarization followed 
by a depolarization. At resting potential, seven cells (53.8% of responding cells) also 
discharged during SPA. Four of these cells showed depolarizing, three showed biphasic 
responses to SPA, firing at 17.7 [10.0-24.0] % of the events (median [±95% confidence 
interval]; Fig. 4F, significantly lower than in epileptic tissue, p<0.05). 
 
Anatomical examinations 
When counting NeuN-immunoreactive neurons, we found slightly lower cell densities 
in all layers in the epileptic (n=14202 neurons from two patients) than in the non-epileptic (n= 
8633 neurons from two patients) neocortex (Fig. 5A, B; Table 8). This is in accordance with 
previous findings showing that neuron numbers are lower in the epileptic neocortex affected 
by focal cortical dysplasia compared to the adjacent, non-affected neocortex (Thom et al., 
2005). Furthermore, neuron density was slightly higher in all layers in the regions where SPA 
was generated than in the area where SPA could not be detected, both in specimens from 
epileptic (SPA: 1820±1338, no SPA: 1694±1244 cell/mm2) and tumour patients (SPA: 
2202±1635, no SPA: 1834±1374 cell/mm2, Table 8). 
To examine the changes of perisomatic inhibition (Del Rio & DeFelipe, 1994), we 
counted the parvalbumin (PV)-positive interneurons in the human epileptic (n=4) and non-
epileptic (n=3) neocortical slices. We determined the density of PV-stained interneurons in 
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areas with and without SPA of the same slice. Density was very variable when comparing 
areas generating and areas lacking SPA. We found no correlation between the presence of 
SPA and the number of PV-stained neurons. The density of PV-positive cells was lower in 
areas with SPA than in regions without SPA in 3 slices from epileptic and in 2 slices from 
tumor patients, but it was higher in one and one slice derived from epileptic and tumor 
patients. On average, PV-positive interneuron density was slightly lower in regions generating 
SPA than areas lacking SPA in epileptic patients (45.0±11.4 cells/mm2 in regions with SPA 
vs. 54.1±19.1 cells/mm2 in regions without SPA), while it was slightly higher in tumor 
patients (87.7±26.9 cells/mm2 in regions with SPA vs. 78.1±14.5 cells/mm2 in regions without 
SPA). As previously described (DeFelipe et al., 1993), the overall density of PV-positive cells 
was significantly lower (p<0.05) in epileptic (49.5±15.4 cells/mm2) than in non-epileptic 
(82.9±20.0 cells/mm2) neocortex. 
Synaptic reorganization has been found in epileptic tissue for both excitatory and 
inhibitory networks (Marco & DeFelipe, 1997). We examined the account of this 
phenomenon on the emergence of SPA by investigating 757 synapses in 5136 µm2 in epileptic 
(n=3) and 679 synapses in 6144 µm2 in tumour (n=3) samples. Asymmetrical (=presumably 
excitatory) and symmetrical (=presumably inhibitory) synapse numbers per unit area were 
determined at electron microscopic level. Synapse densities were similar in areas generating 
and not generating SPA both in epileptic and tumour specimens (Fig. 5C-G, Table 9). 
Interestingly, the density of inhibitory synapses was not lower, but slightly higher in epileptic 
(7.9±1.9 symmetrical synapses/100 µm2) compared to non-epileptic tissue (6.7±1.1 
synapses/100 µm2), as it could have been expected based on the lower numbers of PV-
positive cells. Moreover, the density of excitatory synapses and thus, the total synaptic density 
were significantly higher in epileptic (7.3±2.1 asymmetrical synapses/100 µm2 and 15.2±3.7 
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synapses/100 µm2) than in non-epileptic tissue (4.2±1.0 asymmetrical synapses/100 µm2 and 
10.9±1.8 synapses/100 µm2, p<0.0001). 
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Discussion 
 
Hyperexcitability in the human epileptic neocortex 
The main goal of the present study was to explore how the excess excitation of the 
epileptic neuronal network contributes to the generation of synchronous population bursts. 
The spontaneously occurring SPAs served as an excellent model for the synchronous activity 
of neocortical neural assemblies. We found that the hyperexcitability of the human epileptic 
neocortex is manifested not only at cellular (for review see Avoli et al., 2005), but also at 
network level. In the epileptic compared to non-epileptic neocortex, SPAs occurred in a 
higher proportion of slices, more multiple SPAs were detected, and the LFPg amplitude of 
SPAs was also higher. The higher percentage of depolarizing cells, discharging more 
frequently during SPA also demonstrate the hyperexcitability of the epileptic neuronal 
network (see also McCormick & Contreras, 2001). The increased numbers of excitatory 
synapses together with a slightly decreased neuronal density confirm the phenomenon of 
epileptic synaptic reorganization (Marco & DeFelipe, 1997), and provide further evidence for 
an impaired balance between excitatory and inhibitory signaling in the human neocortex. The 
decreased number of parvalbumin-positive interneurons (staining perisomatic inhibitory 
basket and axo-axonic cells) could indicate an impaired inhibition in the epileptic neocortex 
(see also DeFelipe et al., 1993). However, when we investigated the density of inhibitory 
synapses independent of their parvalbumin, contrary to a previous study (Marco & DeFelipe, 
1997), we did not observe any loss, but a slightly increased number of inhibitory connections 
in the epileptic neocortex. This suggest that inhibitory circuits might also participate in the 
epileptic synaptic reorganization, as they do in the human hippocampus (Wittner et al., 2001). 
High frequency oscillations were detected in the human neocortex during both normal 
and epileptic brain states (Blanco et al., 2010), and increased ripples and fast ripples were 
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proposed to identify the epileptogenic zone (Worrell et al., 2008; Jacobs et al., 2012). Since in 
vitro slice preparations represent considerably altered conditions compared to in vivo human 
neocortical circuitry, solid conclusions cannot be made on the presence of high frequency 
oscillations. However, the same tendency could be observed in our samples as in vivo, i.e. 
higher numbers of SPAs and IIDs were associated with prominent HFOs in epileptic vs. 
tumour tissue. In addition, the HFO power of IIDs was about twice as large compared to that 
of SPAs, supporting the hypersynchronous nature of epileptic processes. 
Our observations indicate that the emergence of population activity is related to the 
level of excitation and synchrony in the human neocortex, although both glutamatergic and 
GABAergic signaling participate in it (see pharmacological results). The generation of SPAs 
in epileptic samples is linked to a higher degree of excitation compared to non-epileptic 
tissue. The sprouting of excitatory connections, as well as the higher numbers of depolarizing 
and more reliably firing cells contribute to the modification of the neocortical neuronal 
network, and seems to facilitate the emergence of SPAs (more slices exhibit SPA, more 
multiple SPAs). The emergence of IIDs is associated with an even more elevated level of 
excitation and synchrony, reflected in the significantly higher values of LFPg, MUA and HFO 
power values. Future studies are needed to define (if possible) the subtle border between 
physiological and pathological processes. 
 
Complexity of the human neocortex 
As in a recent study (Mohan et al., 2015), we found that the total dendritic length of 
human neocortical pyramidal cells (~34 mm) is over three times as large as that of rodents (~9 
to 10 mm; (Ascoli et al., 2007; Krieger et al., 2007; Chen et al., 2014). The exceptionally 
long dendritic tree of human neurons offers the possibility of receiving input from a very large 
number of synapses, and thus, may serve as the anatomical basis of the highly interconnected 
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and reliable neocortical circuitry (Molnár et al., 2008). Human neocortical neurons show 
heterogeneous firing patterns during interictal spikes (Keller et al., 2010), supporting the 
complexity of distinct neuronal groups interacting to generate hypersynchronous discharges. 
The occurrence of multiple SPAs and simultaneous SPAs-IIDs in the same slice also indicate 
the presence of an exceptionally complex neuronal network able to induce different types of 
synchronies. Our results provide further evidence that the anatomical and physiological 
complexity of the human neocortex seems to highly exceed that of rodents. The ability of the 
neocortical neuronal network to spontaneously generate complex synchronies may contribute 
to cognitive functions characteristic to humans. The complexity of the neuronal circuit 
provides the potential of improved encoding capabilities (Fourcaud-Trocme et al., 2003; Ilin 
et al., 2013; Eyal et al., 2014), which might have resulted in an evolutionary benefit for 
humans.  
 
Two distinct types of synchronies generated by human neocortical slices 
In the present study, we show that two types of spontaneous synchronous activities can 
emerge in human neocortical slice preparations. The initiation layers, occurrence rate and 
network characteristics provided a clear distinction between IIDs and SPAs. 
In our records, spontaneous IIDs were generated only in slices from epileptic patients, 
mainly in the granular or infragranular layers, like in vivo interictal spikes (Ulbert et al., 
2004a). The recurrence frequency of IIDs was ~0.05 Hz, a value comparable to the 4-amino-
pyridine induced epileptiform activity recorded in human neocortical slices (0.3 to 0.1 Hz; 
(Avoli et al., 1994) and to spiking activity in the subiculum (~0.15 Hz) of epileptic patients 
(Fabó et al., 2008). The large LFPg transient, the initial current sink and the considerably 
enhanced cell firing recalled the characteristics of interictal spikes detected in vivo (Ulbert et 
al., 2004a; Fabó et al., 2008), and those of the Mg2+-free model of epileptic activity recorded 
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in the human neocortex in vitro (Avoli et al., 1995). The remarkably high ripple and fast 
ripple powers during IIDs further indicate the hypersynchronous nature of these bursts. The 
striking similarity of IIDs to in vivo interictal spikes and to pharmacologically induced 
epileptiform events recorded in human slices suggest that this activity might be linked to 
epileptic processes. The fact that they could be recorded only in specimens originating from 
epileptic patients further supports this idea. 
SPAs described in our samples were significantly different from IIDs, and showed 
remarkable similarities to population activity recorded in epileptic human hippocampal 
(Cohen et al., 2002; Wozny et al., 2005; Huberfeld et al., 2007; Wittner et al., 2009) and 
neocortical (Köhling et al., 1998; Roopun et al., 2010; Pallud et al., 2014) slices. The cellular 
responses of our intracellularly recorded neurons were also comparable to intracellular 
reflections of spontaneous network activity detected in human neocortical neurons 
(Schwartzkroin & Knowles, 1984; Schwartzkroin & Haglund, 1986). SPAs were recorded in 
slices derived from epileptic patients and from tumour patients with no preoperative clinical 
or electrographic manifestations of epileptic activity. Contrary to IIDs, SPAs were initiated 
mainly in the supragranular layers (see also Köhling et al., 1998; Pallud et al., 2014), and 
their recurrence frequency was one order of magnitude higher than that of IIDs. They were 
also characterized by a field potential transient with superimposed high frequency oscillations 
and increased cellular activity. However, all examined network properties (LFPg, CSD, 
MUA, high frequency oscillation power) gave significantly lower values compared to IIDs, 
suggesting that considerably lower numbers of neurons participate in these synchronous 
events.  
 
Epileptic activity in human tissue, in vitro? 
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The question whether human cortical tissue retains its epileptic activity has been 
investigated since the first in vitro human studies (in 1970’s, for review see Avoli et al., 
2005). Spontaneous interictal-like activity was very rarely observed, whereas ictal-like 
activity could be never reported in human preparations, even in tissue derived from brain 
regions chronically involved in seizure activity. However, both interictal and ictal-like 
activities could be induced by appropriate pharmacological agents. The most obvious 
conclusions of these work were that deafferentation might be linked to the disappearance of 
epileptic activity, or that foci of epileptic activity are small, and thus difficult to detect 
(Köhling et al., 1998). The size of the tissue sample – and thus, the number of cells 
constituting the neuronal network – has been related to the emergence of synchronous activity 
in the rodent hippocampus (Wu et al., 2005), suggesting that a minimal number of neurons 
and connections (Wittner & Miles, 2007) are required to generate synchronous activity. A 
systematic study would be needed to reveal what is the smallest subset of a human cortical 
network which can retain its spontaneous epileptic activity. The knowledge about the 
differences in neuron/glia numbers, in synaptic connectivity, differences in 
receptor/transmitter systems in the epileptic cortex compared to non-epileptic samples would 
also help to make an estimation about the smallest tissue sample able to generate epileptic 
activity in vitro. 
The epileptogenicity of the in vitro spontaneous network events is a debated question 
since the beginning of human in vitro research. The picture is notably complex when 
regarding different species and different cortical regions. Since healthy human samples are 
not available, researchers often use animal tissue as control. In vitro spontaneous neocortical 
network events could be detected neither in healthy rodents (Köhling et al., 1998; Avoli et al., 
2005), nor in primates (Schwartzkroin & Haglund, 1986). Complex population bursts could, 
however, be evoked in neocortical slices derived from non-epileptic patients by activating 
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single pyramidal cells (Molnár et al., 2008). Population activity arising in healthy monkey 
hippocampal slices was also considered to be proof that spontaneous synchronous bursts are 
not related to epilepsy (Schwartzkroin & Haglund, 1986). Accordingly, in the last two 
decades, work exploring the spontaneous network activity in the hippocampus of healthy 
rodents consistently correlated this type of events to sharp-wave ripple complexes – the 
physiologically occurring phenomenon thought to participate in learning and memory 
consolidation processes (for review see Buzsáki, 2015). On the other hand, the behavior of 
human neocortical neurons (Prince & Wong, 1981; Schwartzkroin & Knowles, 1984; 
Strowbridge et al., 1992; Avoli et al., 2003; Williamson et al., 2003), and the similarities in 
the wave form of in vitro events and in vivo interictal spikes (Cohen et al., 2002; Pallud et al., 
2014) strengthened the idea that in vitro population bursts are linked to epilepsy. Neocortical 
population events were either compared to sharp waves – the clinical term for the short 
variant of interictal discharges (Köhling et al., 1998; Köhling et al., 1999), or were called 
interictal-like activity (Pallud et al., 2014). In the latter study network events were recorded in 
neocortical slices from tumour patients both with or without preoperative seizures. The 
patients suffered from gliomas known to be highly epileptogenic, and the authors related the 
emergence of these events to the epileptogenicity of the human peritumoural neocortex. In 
summary, some studies indicate that in vitro population activity is not related to epileptic 
processes (Schwartzkroin & Haglund, 1986; Molnár et al., 2008; Szegedi et al., 2016), 
whereas most authors believe in its epileptiform nature (Prince & Wong, 1981; Schwartzkroin 
& Knowles, 1984; Strowbridge et al., 1992; Köhling et al., 1998; Cohen et al., 2002; Avoli et 
al., 2003; Williamson et al., 2003; Pallud et al., 2014). 
Our results strongly support the hypothesis that SPAs are not a direct reflection of 
neocortical epileptogenicity. SPAs detected in slices derived from tumour patients without 
having preoperative clinical and electrographic manifestations of epileptic seizures were very 
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similar in all aspects to those recorded from tissue resected from epileptic patients. 
Furthermore, the higher neuronal density in the spots generating SPA also indicates its non-
pathological feature, since focal cortical epilepsies are linked to neuron loss (Thom et al., 
2005). However, signs of epileptic hyperexcitability can be observed in human epileptic 
neocortical slices, since they can generate IIDs as well, a presumably epileptiform 
synchronous activity.  
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Figure legend 
 
Figure 1. 
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Network characteristics of SPAs in human neocortical slices. 
SPAs were observed in tissue from epileptic patients without tumour (A-B), epileptic patients 
with tumour (C-D) and tumour patients without epilepsy (E-F). Furthermore, IID was 
detected in the epileptic neocortex (G-H). Left panels show LFPg traces from eight (A, C, E) 
channels positioned in the supragranular layers, while (G) shows 23 channels covering the 
entire width of the neocortex, with simultaneously occurring SPA and IID. Asterisks label 
SPA events (A, C, E, G), the triangle (G) indicates the IID event. One SPA and IID event 
each is magnified on the right side (G). Color maps (B, D, F, H) show the CSD and the 
change in MUA. In most SPA cases CSD consisted of a pair or triple of simultaneous sinks 
and sources and were similar in all three patient groups. Warm colors depict sinks, while cold 
colors indicate sources. MUA increase was detected during SPAs and IIDs in almost all cases. 
Warm colors show MUA increase, cold colors label MUA decrease. Note the higher 
amplitude of CSD and MUA in case of IIDs (color scales are the same for all heat maps). 
(I) The recurrence frequency and the MUA were similar for SPAs of epileptic and tumour 
patients. The LFPg amplitudes were significantly larger for SPAs in epileptic patients than in 
tumour patients (LFPg: p<0.01). All of these network characteristics of IIDs were 
significantly different from SPAs detected in epileptic tissue (p<0.01). * labels significant 
difference 
(J) The values of recurrence frequency (Freq), the average of CSD and MUA (CSD&MUA), 
and the intracortical location of all SPAs (black circles) and IIDs (orange circles) from 
epileptic and tumour tissue are shown on a three-dimensional plot.  
Epi: epileptic, Tu: tumour, supra: supragranular, gran: granular, infra: infragranular 
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Figure 2 
Different types of single and multiple SPAs. 
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(A) Different types of SPAs were separated based on their location and extension across the 
neocortical layers. SPAs were found to be spread over supragranular (supra), 
supragranular+granular (supra-gran), granular (gran), granular+infragranular (gran-infra) or 
infragranular (infra) layers or over the entire width of the neocortex (entire). For comparison, 
an IID event is also shown. 
Multiple SPAs occurred more frequently in samples from epileptic and epileptic+tumour 
patients. We differentiated between simultaneous multiple SPAs at one recording site (B) and 
multiple spots of SPAs in the same slice (C).  
(D) The prevalence of the different SPA types was similar in the epileptic and tumour patient 
groups. Most of the SPAs were generated in the supragranular layers, whereas IIDs emerged 
mainly in the deeper layers. 
(E) The AMPA/kainate type glutamate receptor antagonist NBQX blocks the emergence of 
SPAs (upper panel). The NMDA type glutamate receptor antagonist DL-APV reduced the 
frequency of SPAs (middle panel). The GABAA receptor antagonist bicuculline also blocked 
the generation of SPAs (lower panel). All these effects were reversible. 
 44 
 
 
Figure 3 
High frequency oscillations during SPAs. 
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SPAs were more often accompanied by high frequency oscillations in epileptic (A-C) than in 
tumour (D-F) patients. High frequency oscillations were superimposed on IIDs (G-I) at 
similar ratios as on epileptic SPAs. Traces in both ripple (A-B, D-E, G-H middle trace) and 
fast ripple frequency band (A-B, D-E, G-H bottom trace) showed an increased activity during 
SPAs (asterisks on A, D, upper trace) and IIDs (triangles on G, upper trace). (B) and (E) show 
one magnified SPA event, (H) shows one IID event. Note the difference in the amplitude of 
high frequency oscillations between SPAs and IID. 
Arrows indicate peaks at ripple frequency, open end arrows mark the peaks at fast ripple 
frequency on the heat maps (C, F, I, upper panels) and on the line plots made at the LFPg 
peak (at time 0, lower panels) generated using wavelet analysis (C, F, I, lower panels). Time 
frequency analysis (TFR, C, F, I) shows the results obtained on channel 10 (A-B), channel 13 
(D-E), and channel 19 (G-H), respectively. Warm colors depict an increase in frequency 
power, cold colors show a decrease. Note the scale differences between TFR plots. 
A, D: * labels the SPA events, G: triangle shows IID events 
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Figure 4 
Cellular responses of intracellularly recorded cells. 
Human neocortical pyramidal cells showed various behaviors during SPAs (two lower traces) 
in intracellular records (upper trace): depolarizing (A-B), biphasic (C) or hyperpolarizing (D). 
In epileptic tissue, seven out of 11 depolarizing cells were also discharging (A) during SPA. 
In tumour tissue, four out of six depolarizing and all three biphasic cells (C) were also firing 
during SPA, although with significantly lower reliability (F) than neurons from epileptic 
tissue (p<0.05). (E) The ratio of depolarizing cells was significantly higher in epileptic tissue 
(p<0.05), and biphasic cells were only found in tumour tissue. Light micrographs and three-
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dimensional reconstructions show a layer V pyramidal cell from epileptic tissue (G) and a 
layer II pyramidal cell from tumour tissue (H). Note the very complex dendritic arborization 
(red) of human cells, and the truncated apical dendrite of the cell in (G). Axons are shown in 
blue. The same scale bar applies to the micrograph and the reconstruction. 
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Figure 5 
Anatomical data related to SPA generation. 
Neuron and synapse counting was performed on NeuN-stained sections (A). Neuron density 
(B, black boxes on A) and synapse density (C, red boxes on A) were determined in areas 
where SPA was recorded and in areas of the same slice where SPA could not be detected. 
(B) Neuronal densities (n/mm2) were variable in the different layers of the neocortex of 
epileptic and tumour patients. Neuron density was lower in epileptic than in tumour tissue, 
and it was slightly higher in regions with SPA than in areas lacking SPA. (C) Density of 
asymmetrical (excitatory) and symmetrical (inhibitory) synapses (n/100 µm2) in epileptic and 
tumour tissue. No difference was found between areas with or without SPA. The density of 
excitatory synapses was higher in epileptic than in tumour tissue (p<0.001). (D-G) Electron 
micrographs show asymmetrical (open arrows) and symmetrical (filled arrows) synapses from 
epileptic (D, E) and tumour (F, G) tissue, from areas with SPA (D, F) or without SPA (E, G). 
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Tables 
Table 1. Patient data 
Epileptic 
patients 
Gender Age Diagnosis Resected 
cortical 
region 
Duration of epilepsy Stage of 
epilepsy 
Distance 
from 
tumour 
Anatomy of 
obtained tissue 
E1 F 22 encephalitis parietal 1 month A  normal/cell loss 
E2 F 21 focal cortical dysplasia with glioneural heterotopia frontal 2 years A  dysgenetic 
E3 F 18 bilateral frontal polymicrogyria frontal 5 years A  dysgenetic 
E5 F 18 focal cortical dysplasia II B temporal 5 years A  dysgenetic 
E6 M 51 hippocampal sclerosis temporal 50 years A  normal 
E8 F 33 focalis corticalis dysplasia II B occipital 31 years A  normal+dysgenetic 
E10 M 21 hippocampal sclerosis temporal 21 years A  normal 
E11 M 29 cavernous malformation temporal 3 years A  N/A 
E12 M 40 hippocampal sclerosis temporal 35 years A  normal 
E13 F 53 hippocampal sclerosis temporal 40 years A  normal 
E15 M 35 focal cortical dysplasia + hippocampal sclerosis temporal 34 years A  normal 
E16 M 26 subependymal gliosis (dysgenesis) + hippocampal sclerosis temporal 24 years A  normal 
E17 F 38 focal cortical dysplasia + hippocampal sclerosis frontal 31 years A  normal 
E18 F 35 focal cortical dysplasia II B (with balloon cells) frontal 30 years A  normal 
E21 M 56 haemangioma cavernosum temporal 26 years A  N/A 
E23 F 33 haemangioma cavernosum temporal 5 years A  normal 
E25 M 53 hippocampal sclerosis temporal 24 years A  normal 
E27 M 27 hippocampal sclerosis temporal 2 years A  normal 
E29 M 18 focal cortical dysplasia parietal 5 years A  dysgenetic 
E30 M 30 microdysgenesis + hippocampal sclerosis temporal 17 years A  dysgenetic 
E32 F 31 focal cortical dysplasia II B (with balloon cells) parietal 18 years A  dysgenetic 
E34 F 18 hippocampal sclerosis temporal 4 years A  N/A 
E35 F 37 cavernous malformation temporal 6 years A  N/A 
E39 F 36 hippocampal sclerosis temporal 30 years A  N/A 
E42 M 44 subpialis gliosis (dysgenesis) frontal 22 years A  N/A 
E45 M 48 focal cortical dysplasia II B frontal 39 years A  N/A 
Epileptic 
patients 
with 
Gender Age Diagnosis Resected 
cortical 
region 
Duration of epilepsy Stage of 
epilepsy 
Distance 
from 
tumour 
Anatomy of 
obtained tissue 
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tumour 
E4 M 24 ganglioglioma grade I temporal 4 years A distant normal 
E14 M 53 ganglioglioma grade I parietal 18 years A close normal 
E19 F 72 radionecrosis (1 year earlier: astrocytoma grade II) frontal 2 years C close normal 
E20 F 33 glioblastoma grade IV frontal 3 month C distant N/A 
E24 M 71 glioblastoma grade IV frontal 1 week (1 seizure) B close normal 
E26 M 44 anaplastic ganglioglioma grade III temporal 3 months (1 seizure) C distant N/A 
E28 F 60 anaplastic oligodendroglioma grade III, recidiva frontal 10 years B close N/A 
E31 M 31 complex dysembrioplastic neuroepithelial tumour temporal 10 years A distant N/A 
E33 M 63 lung adenocarcinoma metastaticum occipital 2 weeks (1 seizure) C close N/A 
E40 M 32 anaplastic oligoastrocytoma grade III frontal 4 years A distant N/A 
E41 F 26 radionecrosis (2 years earlier: pylocytic astrocytoma) temporal 13 years A close N/A 
E44 F 32 anaplastic astrocytoma grade III frontal N/A (1 seizure) C distant N/A 
E46 F 38 ganglioglioma grade I temporal 10 years A close N/A 
O42 M 72 glioblastoma multiforme frontal 9 months (1 seizure) A distant normal 
T1 F 54 oligodendroglioma grade II frontal 2 weeks (1 seizure) B distant N/A 
T3 F 18 anaplastic ependymoma grade III frontal 1 month B distant normal 
T5 F 35 oligodendroglioma grade III occipital 1 month (1 seizure) B close infiltrated 
T9 F 48 lung small cell carcinoma metastaticum occipital 2 weeks (1 status 
epilepticus) 
B close infiltrated 
T10 M 44 glioblastoma multiforme, astrocytoma grade IV temporal 3 weeks B distant normal 
T13 M 53 radionecrosis (6 years earlier: anaplastic oligoastrocytoma 
grade III) 
frontal 6 years (1 seizure) B distant N/A 
T22 M 65 epidermoid carcinoma metastaticum occipital 13 months (1 seizure) C distant normal 
T31 M 64 lung carcinoma metastaticum temporal 3 months (1 seizure) B distant normal 
T46 F 68 glioblastoma grade IV temporal 2 weeks B close N/A 
Tumour 
patients 
Gender Age Diagnosis Resected 
cortical 
region 
 Stage of 
epilepsy 
Distance 
from 
tumour 
Anatomy of 
obtained tissue 
T2 M 59 glioblastoma multiforme sarcomatosum temporal  D close N/A 
T4 F 69 glioblastoma multiforme temporal  D distant normal 
T6 M 31 cavernoma, haematoma intracerebralis acuta frontal  D distant normal 
T7 F 58 glioblastoma multiforme, meningitis temporal  D close infiltrated 
T8 F 78 glioblastoma multiforme, astrocytoma grade IV temporal  D distant normal 
T11 F 57 glioblastoma multiforme grade IV occipital  D distant normal 
T12 M 59 glioblastoma, with oligodendroglioma fragments grade IV frontal  D close normal 
T14 M 67 lung anaplastic carcinoma metastaticum temporal  D close N/A 
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T15 F 67 meningioma grade I frontal  D distant N/A 
T16 F 69 gastrointestinal adenocarcinoma metastaticum occipital  D close N/A 
T17 F 74 glioblastoma multiforme grade IV parietal  D distant normal 
T18 M 68 melanoma malignum metastaticum parietal  D distant normal 
T19 M 69 lung adenocarcinoma metastaticum parietal  D close N/A 
T20 F 59 breast carcinoma metastaticum frontal  D close infiltrated 
T21 F 69 kidney carcinoma metastaticum parietal  D distant normal 
T23 F 81 meningioma grade I frontal  D distant normal 
T24 M 55 lung adenocarcinoma metastaticum temporal  D distant N/A 
T25 F 55 glioblastoma multiforme parietal  D distant N/A 
T26 F 63 glioblastoma multiforme grade IV parietal  D close N/A 
T27 F 61 lung carcinoma metastaticum frontal  D distant N/A 
T28 M 49 kidney carcinoma metastaticum occipital  D close N/A 
T29 F 62 lung adenocarcinoma metastaticum parietal  D close N/A 
T32 M 79 glioblastoma multiforme grade III temporal  D close N/A 
T33 M 45 anaplastic astrocytoma frontal  D close N/A 
T34 F 64 haematoma frontal  D distant N/A 
T35 M 60 glioblastoma grade IV temporal  D distant N/A 
T38 M 82 stomach anaplastic carcinoma metastaticum temporal  D close N/A 
T39 M 37 centralis neurocytoma grade II frontal  D distant N/A 
T40 M 45 anaplastic astrocytoma grade III temporal  D close N/A 
T42 F 59 breast carcinoma metastaticum frontal  D close N/A 
T43 M 73 melanoma malignum metastaticum  temporal  D distant N/A 
T44 F 58 breast carcinoma metastaticum occipital  D distant N/A 
T45 F 56 glioblastoma grade IV occipital  D distant N/A 
F=female, M=male, N/A=not available, Stage of epilepsy: A: pharmacoresistant epilepsy, B: treatable epilepsy, C: no need for medication, D: no epilepsy 
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Table 2. SPA occurrence in neocortical slices deriving from different lobes of the brain 
 All epileptic patients Epileptic patients without tumour Epileptic patients with tumour Tumour patients without epilepsy 
 n Ratio of 
slices 
generating 
SPA (%, sum 
of slices with 
SPA/sum of 
all slices) 
Ratio of 
slices 
generating 
SPA (%, by 
patient, 
mean±SD) 
n Ratio of 
slices 
generating 
SPA (%, sum 
of slices with 
SPA/sum of 
all slices) 
Ratio of 
slices 
generating 
SPA (%, by 
patient, 
mean±SD) 
n Ratio of 
slices 
generating 
SPA (%, sum 
of slices with 
SPA/sum of 
all slices) 
Ratio of slices 
generating 
SPA (%, by 
patient, 
mean±SD) 
n Ratio of 
slices 
generating 
SPA (%, sum 
of slices with 
SPA/sum of 
all slices) 
Ratio of 
slices 
generating 
SPA (%, by 
patient, 
mean±SD) 
Frontal lobe 15 35.2 35.0±29.4 6 37.1 42.7±34.4 9 34.0 29.8±26.5 10 34.0 34.2±29.2 
Occipital lobe 4 41.2 35.0±27.4 1 66.7 66.7±0.0 3 27.3 24.4±21.4 5 36.4 31.7±31.1 
Parietal lobe 5 47.2 48.7±25.4 3 63.6 66.1±12.1 2 21.4 22.5±3.5 7 33.3 30.3±19.3 
Temporal lobe 25 54.3 55.5±27.7 16 59.3 58.5±24.5 9 46.3 50.0±33.7 11 25.4 24.3±27.8 
Total 49 46.6 46.8±28.9 26 55.0 56.1±25.9 23 37.1 36.4±29.0 33 31.1 29.7±26.3 
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Table 3. Relationship of SPA occurrence and aetiology 
  Number 
of 
patients 
Ratio of slices 
generating SPA 
(%, sum of slices 
with SPA/sum of 
all slices) 
Ratio of slices 
generating SPA 
(% by patient, 
mean±SD) 
Epileptic Dysgenesis 13 54.9 58.3±28.6 
Hippocampal sclerosis 8 57.1 56.1±17.5 
Other 5 52.0 50.3±34.0 
Tumour 23 37.1 36.4±29.0 
Total 49 46.6 46.8±28.9 
Tumour Glial tumour 31 38.1 38.7±28.6 
Carcinoma metastasis 18 23.7 20.6±21.3 
Other tumour 7 35.9 35.0±29.0 
Total 56 33.5 32.4±27.4 
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Table 4. SPA distribution across neocortical layers. Number of SPAs (and IIDs) are provided appearing as single or as part of multiple SPAs, in 
the different layers of the human neocortex. 
SPAs in neocortical layers Epileptic patients without tumour Epileptic patients with tumour Tumour patients without epilepsy 
Single 
SPA 
Multiple 
SPA 
Total  
SPA (%) 
IID Single 
SPA 
Multiple 
SPA 
Total  
SPA (%) 
IID Single 
SPA 
Multiple 
SPA 
Total  
SPA (%) 
Supra 35 41 76 (56.3%) 0 18 17 35 (49.3%) 0 33 17 50 (53.8%) 
Supra-gran 12 12 24 (17.8%) 0 6 6 12 (16.9%) 1 6 7 13 (14.0%) 
Gran 5 10 15 (11.1%) 1 3 4 7 (9.9%) 0 3 11 14 (15.1%) 
Gran-infra 0 6 6 (4.4%) 5 0 1 1 (1.4%) 0 1 3 4 (4.3%) 
Infra 2 7 9 (6.7%) 2 1 7 8 (11.3%) 0 2 8 10 (10.8%) 
Entire 2 3 5 (3.7%) 0 4 4 8 (11.3%) 0 0 2 2 (2.2%) 
Total number of SPAs or IIDs 56 79 135 8 32 39 71 1 45 48 93 
Number of slices with SPAs or 
IIDs  
(% of slices with SPA/IID) 
56  
(66.7%) 
28  
(33.3%) 
84  
(54.9%) 
6  
(7.1%) 
32  
(65.3%) 
16  
(32.7%) 
49  
(36.6%) 
1  
(2.0%) 
45  
(75%) 
15  
(25%) 
60  
(30.9%) 
Total number of examined 
slices 
153 134 194 
Supra = supragranular (layers I-III) layers, Supra-gran = supragranular+granular (layer IV) layers, Gran = granular layer, Gran-infra = 
granular+infragranular (layers V-VI) layers, Infra = infragranular layers, Entire = entire width of the neocortex, involving 
supragranular+granular+infragranular layers, see also Fig. 2) 
 56 
 
Table 5. Network properties of human neocortical SPAs and IIDs.  
  Number of 
SPAs/IIDs 
analysed 
Recurrence 
frequency (Hz) 
Largest LFPg 
amplitude (µV) 
Width at half of the 
maximal amplitude 
(ms) 
Asymmetry at half of 
the maximal 
amplitude (right/left) 
Largest CSD 
amplitude (µV) 
Largest MUA 
amplitude (µV) 
E
p
il
e
p
ti
c 
S
P
A
 
Total SPA 46 1.03 [0.91  1.22] 
(1.20 ± 0.71) 
23.22 [18.59  27.01] 
(27.31 ± 17.23) 
26.35 [23.75  31.85] 
(34.09 ± 20.43) 
1.55 [1.45  1.77] 
(1.72 ± 0.64) 
14.30 [12.92  16.97] 
(16.76 ± 8.79) 
1.06 [0.77  1.12] 
(1.49 ± 1.46) 
Supragran 
SPA 
38 1.04 [0.88  1.31] 
(1.22 ± 0.67) 
23.38 [18.82  28.72] 
(28.25 ± 18.14) 
26.35 [23.60  31.65] 
(33.89 ± 21.53) 
1.63 [1.46  1.91] 
(1.79 ± 0.62) 
14.30 [12.91  17.77] 
(17.14 ± 9.03) 
1.10 [0.93  1.42] 
(1.65 ± 1.55) 
Infragran 
SPA 
7 0.99 [0.13  1.74] 
(1.06 ± 0.96) 
17.67 [14.77  27.81] 
(22.65 ± 12.87) 
24.70 [22.75  39.30] 
(31.53 ± 12.40) 
1.09 [0.92  1.57] 
(1.23 ± 0.54) 
13.56 [8.66  18.35] 
(14.86 ± 8.50) 
0.75 [0.28  1.06] 
(0.68 ± 0.38) 
T
u
m
o
u
r 
S
P
A
 
Total SPA 48 1.06 [0.90  1.38] 
(1.18 ± 0.60) 
15.41 [12.82  20.47] 
(18.40 ± 10.48) 
23.05 [21.00  25.85] 
(24.98 ± 11.23) 
1.46 [1.20  1.59] 
(1.62 ± 0.78) 
10.08 [8.14  12.98] 
(12.05 ± 6.34) 
0.90 [0.68  1.17] 
(1.29 ± 1.17) 
Supragran 
SPA 
36 1.08 [0.89  1.39] 
(1.16 ± 0.58) 
16.09 [12.74  20.61] 
(18.64 ± 10.51) 
23.70 [21.10  27.40] 
(26.10 ± 11.98) 
1.41 [1.15  1.57] 
(1.58 ± 0.80) 
11.06 [8.50  13.19] 
(12.36 ± 6.46) 
0.73 [0.57  1.09] 
(1.11 ± 1.12) 
Infragran 
SPA 
11 0.98 [0.57  1.81] 
(1.17 ± 0.69) 
13.08 [7.39  25.67] 
(16.97 ± 11.07) 
21.00 [17.70  27.55] 
(21.58 ± 8.50) 
1.65 [1.03  2.21] 
(1.75 ± 0.78) 
7.84 [6.45  15.43] 
(10.70 ± 6.24) 
1.76 [0.87  2.93] 
(1.90 ± 1.22) 
Epileptic IID 
8 0.05 [0.02  0.14] 
(0.10 ± 0.13) 
74.36 [60.16  100.34] 
(74.70 ± 21.99) 
37.00 [19.30  52.55] 
(40.69 ± 20.19) 
1.77 [1.30  2.62] 
(1.92 ± 1.04) 
42.97 [40.86  52.21] 
(46.09 ± 10.05) 
5.81 [1.66  8.94] 
(6.46 ± 4.57) 
Significant differences Epi SPA > Epi IID 
p<0.0001 
Epi SPA > Tumour 
SPA p<0.01 
Epi supra > Tumour 
supra p<0.01 
Epi IID > Epi SPA 
p<0.0001 
Epi SPA > Tumour 
SPA p<0.05 
n.s. Epi SPA > Tumour 
SPA p<0.01 
Epi supra > Tumour 
supra p<0.05 
Epi IID > Epi SPA 
p<0.0001 
Epi IID > Epi 
SPA p<0.01 
We provided median [95% confidence interval of the median] (mean±SD), since none of the examined parameters showed Gaussian distribution. 
Epi=epileptic, n.s.=non-significant, Supragran = supra, supra-gran and gran SPAs, Infragran = gran-infra and infra SPAs 
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Table 6. High frequency oscillations (HFO) during SPA and IID. Ripple (130-250 Hz) and fast ripple (300-800 Hz) frequencies were examined 
in neocortical slices with SPA and IID. 
 
 Number of SPAs/IIDs (n) 
Ripple frequency (Hz) Ripple power 
Fast ripple frequency 
(Hz) 
Fast ripple 
power 
Total 
(n) 
 
With  
HFO 
Without 
HFO 
With ripple 
activity 
With fast 
ripple activity 
E
p
il
e
p
ti
c 
S
P
A
 
Total 
46 38 
(82.6%) 
8 
(17.4%) 
35 
(76.1%) 
29 
(63.0%) 
178.00 [161.00  193.00] 
(180.89 ± 37.39) 
1.77 [1.45  2.31] 
(2.07 ± 1.03) 
440.00 [400.00  512.00] 
(475.55 ± 130.24) 
1.44 [1.15  1.69] 
(1.75 ± 0.91) 
Supragran 
SPA 
38 32 
(84.2%) 
6 
(15.8%) 
29 
(76.3%) 
24 
(63.2%) 
180.00 [164.00  193.00] 
(184.14 ± 36.99) 
1.70 [1.45  2.24] 
(2.09 ± 1.06) 
437.50 [400.00  534.00] 
(486.75 ± 136.83) 
1.43 [1.15  1.73] 
(1.67 ± 0.91) 
Infragran 
SPA 
7 6 
(85.7%) 
1 
(14.3%) 
6 
(85.7%) 
5 
(71.4%) 
161.50 [127.50  206.50] 
(165.17 ± 38.57) 
2.19 [0.82  2.84] 
(1.95 ± 0.95) 
471.00 [329.00  500.00] 
(421.80 ± 81.94) 
2.26 [0.91  3.07] 
(2.15 ± 0.87) 
T
u
m
o
u
r 
S
P
A
 
Total 
48 33 
(68.8%) 
15 
(31.3%) 
30 
(62.5%) 
26 
(54.2%) 
198.00 [187.00  214.50] 
(208.83 ± 43.35) 
2.02 [1.61  2.87] 
(2.34 ± 1.08) 
462.50 [438.00  573.00] 
(508.81 ± 110.31) 
1.47 [1.31  2.20] 
(1.83 ± 0.80) 
Supragran 
SPA 
36 24 
(66.7%) 
12 
(33.3%) 
21 
(58.3%) 
19 
(52.8%) 
194.00 [179.00  219.00] 
(209.86 ± 48.24) 
1.80 [1.42  2.71] 
(2.17 ± 1.16) 
522.00 [445.00  624.00] 
(535.69 ± 113.84) 
1.36 [1.20  1.69] 
(1.60 ± 0.70) 
Infragran 
SPA 
11 8 
(72.7%) 
3 
(27.3%) 
8 
(72.7%) 
6 
(54.5%) 
208.50 [197.00  248.00] 
(208.75 ± 32.71) 
3.15 [2.56  3.37] 
(2.89 ± 0.68) 
433.50 [381.00  488.00] 
(434.17 ± 62.96) 
2.77 [2.00  3.10] 
(2.62 ± 0.67) 
Epileptic IID 
8 7 
(87.5%) 
1 
(12.5%) 
6 
(75.0%) 
7 
(87.5%) 
147.95 [135.25  226.30] 
(169.83 ± 52.33) 
4.90 [3.69  6.04] 
(4.88 ± 1.09) 
397.50 [317.40  689.00] 
(459.46 ± 168.76) 
4.01 [3.37  4.23] 
(4.11 ± 1.25) 
Significant differences 
n.s. n.s. n.s. Epi SPA < Tumour SPA 
p<0.01 
Epi SPA < Epi 
IID p<0.001 
n.s. 
 
Epi SPA < Epi 
IID p<0.001 
Epi=epileptic, n.s.=non-significant, Supragran = supra, supra-gran and gran SPAs, Infragran = gran-infra and infra SPAs 
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Table 7. Characteristics of intracellularly recorded cells 
Cells from epileptic 
tissue 
Cortex Cell location 
(anatomically identified, 
layer) 
RMP 
(mV) 
Spontaneous 
firing 
SPA location 
(layer) 
Response to SPA Firing during SPA (% of 
events) 
E3Cell1 frontal supra -58.7 silent no SPA -  
E3Cell2 frontal infra (reconstructed, L5) -55.5 firing no SPA -  
E5Cell1 frontal infra -54.0 silent no SPA -  
E5Cell2 frontal infra -54.9 silent no SPA -  
E8Cell1 occipital supra -54.9 firing supra-gran depolarizing+firing 43.5% 
E10Cell1 temporal infra (reconstructed, L5) -52.9 firing supra no response  
E13Cell2 temporal infra (identified, L5) -58.0 silent infra depolarizing+firing 14.3% 
E13Cell3 temporal supra (identified, L3) -68.0 silent supra depolarizing  
E15Cell1 temporal supra -59.5 firing supra-gran depolarizing+firing 96.5% 
E15Cell2 temporal supra -59.8 firing supra depolarizing+firing 55.6% 
E15Cell3 temporal supra (identified, L2) -67.4 silent supra-gran depolarizing  
E16Cell1 temporal supra -55.5 silent supra depolarizing  
gran no response  
gran-infra depolarizing  
E16Cell2 temporal supra -52.4 silent supra depolarizing  
gran depolarizing  
gran-infra depolarizing  
E16Cell3 temporal supra -55.0 firing supra depolarizing+firing 29.8% 
gran no response  
gran-infra depolarizing  
E16Cell4 temporal infra (reconstructed, L5) -75.0 silent supra no response  
gran no response  
gran-infra depolarizing+firing 36.3% 
E17Cell1 temporal supra -53.1 firing supra hyperpolarizing  
E17Cell2 temporal supra -52.2 firing supra depolarizing+firing 86.7% 
Total (n=17)   -58.3±6.5 9 silent/8 firing  11 depolarizing 
1 hyperpolarizing 
51.8±30.1% 
(7/12 cells firing) 
        
Cells from tumour 
tissue 
Cortex Cell location 
(anatomically identified, 
layer) 
RMP 
(mV) 
Spontaneous 
firing 
SPA location 
(layer) 
Response to SPA Firing during SPA (% of 
events) 
T2Cell1 frontal supra -53.1 firing supra hyperpolarizing  
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T2Cell2 frontal supra -54.6 firing supra biphasic+firing 7.0% 
T2Cell3 frontal supra (reconstructed, L2) -71.0 firing gran depolarizing+firing 11.1% 
T8Cell1 temporal supra (identified, L3) -64.2 silent supra hyperpolarizing  
T8Cell2 temporal supra -64.1 firing supra biphasic+firing 24.0% 
T11Cell1 occipital supra -50.1 firing supra depolarizing+firing 21.7% 
T14Cell1 frontal supra -54.7 firing supra hyperpolarizing  
T14Cell2 frontal infra -55.3 firing supra-gran biphasic+firing 17.6% 
T15Cell2 frontal infra -51.1 firing no SPA -  
T17Cell1 parietal supra -52.0 silent no SPA -  
T17Cell2 parietal supra -75.0 silent supra depolarizing  
T18Cell1 parietal supra -68.0 firing supra no response  
gran no response  
supra2 depolarizing+firing 10.0% 
T23Cell1 parietal supra -56.7 silent supra depolarizing  
T23Cell2 parietal supra -61.9 firing supra depolarizing+firing 39.3% 
T26Cell1 parietal supra -54.8 firing supra hyperpolarizing  
T38Cell1 parietal supra (identified, L3) -50.2 firing no SPA -  
Total (n=16)   -58.5±7.8 5 silent/11 
firing 
 6 depolarizing 
3 biphasic 
4 hyperpolarizing 
18.7±11.0% 
7/13 cells firing 
Supra: supragranular, infra: infragranular, L2, L3, L5: layer 2, 3, 5 
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Table 8. Neuron density in the neocortex generating or not generating SPA 
 Epileptic Tumour 
 Number 
of cells 
counted 
Neuron density 
(n/mm2) 
SPA 
Neuron density 
(n/mm2) 
No SPA 
Number 
of cells 
counted 
Neuron density 
(n/mm2) 
SPA 
Neuron density 
(n/mm2) 
No SPA 
Layer I 367 476±81 389±46 116 705±199 398±10 
Layer II 3 055 3 506±707 3 129±98 939 4 327±57 3 170±965 
Layer III 3 415 1 866±81 1 683±8 2 727 2 132±27 1 821±717 
Layer IV 2 890 3 251±77 3 162±227 1 840 3 938±179 3 700±1 172 
Layer V 3 913 1 462±107 1 428±112 2 292 1 753±391 1 496±778 
Layer VI 562 361±223 372±97 719 360±356 421±334 
Total 14 202 1 820±1 338 1 694±1 244 8 633 2 202±1 635 1 834±1 374 
 
 
Table 9. Number of excitatory (asymmetrical) and inhibitory (symmetrical) synapses in areas generating or not generating SPA. 
 Examined 
area (µm2) 
Excitatory synapses Inhibitory synapses All synapses Ratio of excitatory / 
inhibitory synapses Number (% of total) Number per 
100 µm2 
Number (% of total) Number per 
100 µm2 
Number Number per 100 
µm2 
Epileptic SPA 2 904  199 (49.4±5.3%) 7.3±2.2 204 (50.6±5.3%) 7.3±1.9 403 14.6±3.9 0.99±0.21 
Epileptic No SPA 2 232  165 (46.2±9.2%) 7.4±2.6 189 (53.8±9.2%) 8.4±2.2 354 15.8±4.1 0.89±0.31 
Tumour SPA 3 393  149 (37.8±7.7%) 4.3±1.5 233 (62.2±7.7%) 6.8±0.7 382 11.1±2.0 0.62±0.19 
Tumour No SPA 2 751  112 (38.0±5.2%) 4.0±0.7 185 (62.0±5.2%) 6.6±1.6 297 10.7±2.0 0.62±0.14 
 
